Clinical Trials
3 trialsNCT06711523 2025-11-25
Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy
Kexing Biopharm Co., Ltd.
Phase 3 Active not recruiting
NCT02467868 2022-02-14
Efficacy and Safety Study With MYL-1401H and Neulasta
Viatris Inc.
Phase 3 Completed
NCT04101760 2019-10-08
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Phase 3 Unknown